Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 3
1994 1
1995 2
1996 3
1998 1
1999 1
2000 2
2001 1
2002 1
2003 2
2004 3
2005 6
2006 7
2007 9
2008 8
2009 1
2010 3
2011 3
2012 4
2013 3
2014 5
2015 7
2016 10
2017 1
2019 5
2020 6
2021 4
2022 9
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
The growth of siRNA-based therapeutics: Updated clinical studies.
Zhang MM, Bahal R, Rasmussen TP, Manautou JE, Zhong XB. Zhang MM, et al. Among authors: manautou je. Biochem Pharmacol. 2021 Jul;189:114432. doi: 10.1016/j.bcp.2021.114432. Epub 2021 Jan 26. Biochem Pharmacol. 2021. PMID: 33513339 Free PMC article. Review.
Emerging Therapeutic Modalities against COVID-19.
Malik S, Gupta A, Zhong X, Rasmussen TP, Manautou JE, Bahal R. Malik S, et al. Among authors: manautou je. Pharmaceuticals (Basel). 2020 Aug 8;13(8):188. doi: 10.3390/ph13080188. Pharmaceuticals (Basel). 2020. PMID: 32784499 Free PMC article. Review.
Nephrotoxicity of marketed antisense oligonucleotide drugs.
Wu H, Wahane A, Alhamadani F, Zhang K, Parikh R, Lee S, McCabe EM, Rasmussen TP, Bahal R, Zhong XB, Manautou JE. Wu H, et al. Among authors: manautou je. Curr Opin Toxicol. 2022 Dec;32:100373. doi: 10.1016/j.cotox.2022.100373. Epub 2022 Oct 21. Curr Opin Toxicol. 2022. PMID: 37193356
Casimersen for the treatment of Duchenne muscular dystrophy.
Zakeri SE, Pradeep SP, Kasina V, Laddha AP, Manautou JE, Bahal R. Zakeri SE, et al. Among authors: manautou je. Trends Pharmacol Sci. 2022 Jul;43(7):607-608. doi: 10.1016/j.tips.2022.04.009. Epub 2022 May 14. Trends Pharmacol Sci. 2022. PMID: 35581038 No abstract available.
Rethinking Subthreshold Effects in Regulatory Chemical Risk Assessments.
Agathokleous E, Barceló D, Aschner M, Azevedo RA, Bhattacharya P, Costantini D, Cutler GC, De Marco A, Docea AO, Dórea JG, Duke SO, Efferth T, Fatta-Kassinos D, Fotopoulos V, Ginebreda A, Guedes RNC, Hayes AW, Iavicoli I, Kalantzi OI, Koike T, Kouretas D, Kumar M, Manautou JE, Moore MN, Paoletti E, Peñuelas J, Picó Y, Reiter RJ, Rezaee R, Rinklebe J, Rocha-Santos T, Sicard P, Sonne C, Teaf C, Tsatsakis A, Vardavas AI, Wang W, Zeng EY, Calabrese EJ. Agathokleous E, et al. Among authors: manautou je. Environ Sci Technol. 2022 Aug 16;56(16):11095-11099. doi: 10.1021/acs.est.2c02896. Epub 2022 Jul 25. Environ Sci Technol. 2022. PMID: 35878124 No abstract available.
Molecular mechanisms underlying chemical liver injury.
Gu X, Manautou JE. Gu X, et al. Among authors: manautou je. Expert Rev Mol Med. 2012 Feb 3;14:e4. doi: 10.1017/S1462399411002110. Expert Rev Mol Med. 2012. PMID: 22306029 Free PMC article. Review.
100 results